Drug Shortage Report for VIVAXIM

Last updated on 2019-09-06 History
Report ID 1300
Drug Identification Number 02248361
Brand name VIVAXIM
Common or Proper name Combined purified Vi polysaccharide typhoid and inactivated hepatitis A vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE HEPATITIS A VACCINE, INACTIVATED
Strength(s) 25MCG 160UNIT
Dosage form(s) SOLUTION SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1 x 1.0 mL (single dose) dual chamber syringe / 1 seringue (dose unique) à double compartiment de 1,0 mL
ATC code J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-11-16
Actual start date 2016-11-16
Estimated end date 2019-01-31
Actual end date 2019-09-05
Shortage status Resolved
Updated date 2019-09-06
Company comments The shortage has been resolved.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-09-06 English Compare
v12 2019-09-05 French Compare
v11 2019-09-05 English Compare
v10 2017-08-03 French Compare
v9 2017-08-03 English Compare
v8 2017-04-11 French Compare
v7 2017-04-11 English Compare
v6 2017-03-13 French Compare
v5 2017-03-13 English Compare
v4 2017-03-13 English Compare
v3 2017-03-13 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare